However, the outcome of PD1–PD-L1 blockade therapy is not always in accordance with PD-L1 expression in melanoma [9, 15, 16], suggesting that PD-L1 expression alone is a poor predictor for response to PD1–PD-L1 blockade therapy. This evidence concerns the gene CD274 and melanoma.